Maverick Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.8M	Buy	3,567,372 +1,054,262	+42%	+$4.19M	0.15%	52
2025 Q4	$8.82M	Sell	2,513,110 -5,955,234	-70%	-$20.4M	0.09%	56
2025 Q3	$27.6M	Buy	8,468,344 +104,531	+1%	+$329K	0.37%	50
2025 Q2	$20.5M	Buy	8,363,813 +3,164,595	+61%	+$16M	0.31%	49
2025 Q1	$34.7M	Buy	5,199,218 +318	+0%	+$3.14K	0.62%	46
2024 Q4	$65.4M	Buy	5,198,900 +1,080,228	+26%	+$16.3M	1.18%	30
2024 Q3	$76.1M	Buy	4,118,672 +190,360	+5%	+$3.9M	1.48%	23
2024 Q2	$84.6M	Buy	3,928,312 +40,000	+1%	+$919K	1.6%	21
2024 Q1	$105M	Sell	3,888,312 -145,756	-4%	-$4.14M	2.03%	13
2023 Q4	$121M	Sell	4,034,068 -1,595,902	-28%	-$35.2M	2.49%	6
2023 Q3	$115M	Buy	5,629,970 +1,250,000	+29%	+$22.7M	2.7%	7
2023 Q2	$87M	Sell	4,379,970 -27,653	-0.6%	-$559K	1.86%	15
2023 Q1	$75.5M	Buy	4,407,623 +1,011,805	+30%	+$19.8M	1.94%	11
2022 Q4	$66.5M	Buy	3,395,818 +863,452	+34%	+$15.9M	1.62%	16
2022 Q3	$40.4M	Hold	2,532,366	–	–	0.91%	23
2022 Q2	$34.8M	Buy	2,532,366 +399,200	+19%	+$4.76M	0.87%	24
2022 Q1	$33.8M	Buy	2,133,166 +238,200	+13%	+$4.12M	0.61%	37
2021 Q4	$41.4M	Buy	1,894,966 +234,850	+14%	+$6.41M	0.5%	47
2021 Q3	$49.6M	Buy	1,660,116 +1,486,229	+855%	+$54.1M	0.55%	44
2021 Q2	$7.7M	Buy	+173,887	New	+$7.55M	0.07%	85

Other funds holding RCKT